Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

Assertio (NASDAQ:ASRT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. Separately, HC ...

Scilex (NASDAQ:SCLX – Get Free Report) is projected to release its earnings data before the market opens on Monday, March ...

Gout flares cause severe pain, reduced quality of life (2), decreased ... XRx-008 program for ADPKD; and 3) XRx-101 for acute kidney and other acute organ injury associated with respiratory virus ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Explore how stress disrupts digestion from gut motility to nutrient absorption and learn how to restore digestive balance ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

Experts agree that viscosupplementation is a viable option for patients with type 1 or type 2 diabetes, gout, metabolic ... effusions (> 20 mL), acute knee OA flare-ups, and inflammatory knee ...

Generated record quarterly net revenues of $190.6 million, representing year-over-year growth of 44.8%; Total Rare Disease quarterly net revenue of $87.0 million, which includes: ...